Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Gilbert. Study-provided care at no cost to qualified participants.
Access multiple myeloma specialists in Gilbert at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma treatment provided free
The purpose of this study is to evaluate whether elranatamab monotherapy can provide clinical benefit compared to lenalidomide monotherapy (control) in participants with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant. In Part 1 and Part 2 of the study, participants in the study will either receive elranatamab (arm A and C) as an injection under the skin at the study clinic or lenalidomide orally once daily at home (arm B). Participation in the study will be app
Sponsor: Pfizer
Check if you qualify for this multiple myeloma clinical trial in Gilbert, AZ
If you're searching for multiple myeloma treatment options in Gilbert, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Gilbert research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.